Statistics for Immune checkpoint inhibitor treatment in patients with oncogene- addicted non-small cell lung cancer (NSCLC): summary of a multidisciplinary round-table discussion
Total visits
| views | |
|---|---|
| Immune checkpoint inhibitor treatment in patients with oncogene- addicted non-small cell lung cancer (NSCLC): summary of a multidisciplinary round-table discussion | 157 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 1 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| berghoff-esm-immu.pdf(legacy) | 198 |
| berghoff-esm-immu.pdf | 50 |
Top country views
| views | |
|---|---|
| United States | 122 |
| China | 10 |
| Germany | 4 |
| Spain | 4 |
| Australia | 3 |
| Sweden | 3 |
| Argentina | 2 |
| France | 2 |
| Ukraine | 2 |
| Belgium | 1 |
| Czechia | 1 |
| Ireland | 1 |
| South Korea | 1 |
| Mongolia | 1 |
Top city views
| views | |
|---|---|
| Ashburn | 28 |
| San Ramon | 17 |
| Fairfield | 16 |
| Ann Arbor | 12 |
| Boardman | 11 |
| Mountain View | 10 |
| Shenzhen | 8 |
| Cambridge | 7 |
| Barcelona | 4 |
| San Diego | 3 |
| Federal | 2 |
| Jacksonville | 2 |
| Dublin | 1 |
| Menlo Park | 1 |
| Portland | 1 |
| Rochester | 1 |
| Sacramento | 1 |
| San Jose | 1 |
| Seattle | 1 |
| Sükhbaatar | 1 |